In-depth glyco-peptidomics approach reveals unexpected diversity of glycosylated peptides and atypical post-translational modifications in dendroaspis angusticeps snake venom by Degueldre, Michel et al.
 International Journal of 
Molecular Sciences
Article
In-Depth Glyco-Peptidomics Approach Reveals
Unexpected Diversity of Glycosylated Peptides and
Atypical Post-Translational Modifications in
Dendroaspis angusticeps Snake Venom
Michel Degueldre 1, Julien Echterbille 1, Nicolas Smargiasso 1 ID , Christian Damblon 2,
Charlotte Gouin 3, Gilles Mourier 3, Nicolas Gilles 3, Edwin De Pauw 1 and Loïc Quinton 1,*
1 Mass Spectrometry Laboratory, MolSys Research Unit, University of Liege, 4000 Liege, Belgium;
mdeg2127@gmail.com (M.D.); jechterbille@ulg.ac.be (J.E.); nsmargiasso@ulg.ac.be (N.S.);
e.depauw@ulg.ac.be (E.D.P.)
2 Centre de resonance magnétique nucléaire, MolSys Research Unit, University of Liege, 4000 Liege, Belgium;
c.damblon@ulg.ac.be
3 Commissariat à l’énergie atomique et aux énergies alternatives, DSV, iBiTec-S, SIMOPRO,
91190 Gif-Sur-Yvette, France; charlotte.gouin@cea.fr (C.G.); gilles.mourier@cea.fr (G.M.);
nicolas.gilles@cea.fr (N.G.)
* Correspondence: loic.quinton@ulg.ac.be; Tel.: +32-(0)4-366-3679; Fax: +32-(0)4-366-3413
Received: 23 October 2017; Accepted: 9 November 2017; Published: 18 November 2017
Abstract: Animal venoms represent a valuable source of bioactive peptides that can be derived
into useful pharmacological tools, or even innovative drugs. In this way, the venom of
Dendroaspis angusticeps (DA), the Eastern Green Mamba, has been intensively studied during recent
years. It mainly contains hundreds of large toxins from 6 to 9 kDa, each displaying several disulfide
bridges. These toxins are the main target of venom-based studies due to their valuable activities
obtained by selectively targeting membrane receptors, such as ion channels or G-protein coupled
receptors. This study aims to demonstrate that the knowledge of venom composition is still limited
and that animal venoms contain unexpected diversity and surprises. A previous study has shown
that Dendroaspis angusticeps venom contains not only a cocktail of classical toxins, but also small
glycosylated peptides. Following this work, a deep exploration of DA glycopeptidome by a dual
nano liquid chromatography coupled to electrospray ionization mass spectrometry (nanoLC-ESI-MS)
and Matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS)
analyses was initiated. This study reveals unsuspected structural diversity of compounds such as
221 glycopeptides, displaying different glycan structures. Sequence alignments underline structural
similarities with natriuretic peptides already characterized in Elapidae venoms. Finally, the presence
of an S-cysteinylation and hydroxylation of proline on four glycopeptides, never described to
date in snake venoms, is also revealed by proteomics and affined by nuclear magnetic resonance
(NMR) experiments.
Keywords: venomics; glycopeptidome; Dendroaspis angusticeps; glycotoxins
1. Introduction
Snake venoms are classically composed of large toxins that affect the central nervous, the cardiac,
and the neuromuscular systems. Venom toxicity is due to the ability of these toxins to selectively
bind at low concentrations to membrane receptors, such as ion channels (ICs) or G-protein coupled
receptors (GPCRs). However, it was demonstrated several decades ago that these properties
can be exploited by deriving these toxic peptides into selective molecular scalpels or innovative
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drugs. Following this idea, the venom of Dendroaspis angusticeps (Eastern Green Mamba) has
been analyzed by bi-dimensional liquid chromatography and mass spectrometry, revealing more
than 300 different toxins (5–10 kDa, [1]). Among them, several were deeply studied and led
to the discovery of innovative pharmacological tools, such as ligands of various subtypes of
muscarinic receptors [2,3], selective ligands ofα1a-adrenoreceptors (ρ-Da1a, [1]), orα2-adrenoreceptors
(ρ-Da1b, [4]). Another toxin, called mambaquaretine-1, was isolated and characterized for its potency
to selectively antagonize vasopressin type 2 receptors [5]. This activity is being exploited for the
development of therapeutic strategies against polycystic kidney disease, an unmet medical need.
All these previous toxins display masses below 5 kDa and are constrained with 3–5 disulfide bridges,
a classical post-translational modification (PTM) found in animal toxins. Even if toxins from cone
snails are known to exhibit a large variety of PTMs such as amidation, hydroxylation (proline, valine,
etc.), or N-ter pyroglutamylation [6], only few works concretely describe the presence of unusual
PTMs in snake toxins. Palmitoylation of phospholipases A2 in Agksitrodon piscivorus piscivorus [7],
γ-carboxylation of glutamic acids [8], and N- and O-glycosylations [9] constitute the main works
dedicated to this issue. Additionally, a recent study demonstrated the presence of smaller atypical
peptides in Dendroaspis angusticeps (DA) venom [10]. These peptides are not only atypical due to their
limited size but also due to their high number of prolines and their glycosylation.
The present work proposes to perform a deep exploration of DA glycopeptidome, through an
ESI (electrospray ionization)/MALDI (matrix-assisted laser desorption/ionization) dual approach.
ESI is a technique that ionizes molecules directly from the liquid phase [11], whereas MALDI is
exclusively related to samples dispersed in a crystalline matrix [12]. Since these two techniques are
based on different processes of ionization, the use of both techniques constitutes a seducing approach
to make the study as exhaustive as possible. Glycopeptides were detected among the more classical
toxins thought to monitor the neutral losses of sugars and oxonium ions of glycans thanks to tandem
mass spectrometry experiments. ESI and MALDI ionization processes were considered in order to
obtain a complementary view of the glycopeptidome. The combination of these approaches led
to the characterization of 228 unique glycosylated peptides among which 12 were fully de novo
sequenced. A particularly unusual family of toxin was characterized. The structure revealed not only a
glycosylation, but also a C-terminal amidation, a hydroxyproline, and a very atypical S-cysteinylation.
Given the number and the nature of the post-translational modifications carried by this compound,
a structural analysis of the toxin combining mass spectrometry and NMR was considered for one
of them. Moreover, thanks to an alignment sequence search, these new highly-modified peptides
revealed sequence similarities with natriuretic bioactive peptides discovered in other Elapidae venoms.
2. Results
Glycopeptidome Characterization
MALDI and ESI ionizations being complementary, LC-MALDI-TOF-MS, as well as
nanoLC-nESI-Orbitrap experiments were carried out. This dual approach aims to detect and to
characterize a maximum of glycopeptides. In LC-MALDI-TOF experiment, MS/MS spectra were
acquired for all the peptides belonging to the 700–4000 m/z range. Each spectrum was analyzed
by looking for typical neutral losses of monosaccharide such as 162 Da for Hex (hexose), 203 Da
for HexNAc (N-acetyl hexosamine), or 291 for NeuAc (N-acetyl neuraminic acid or sialic acid).
This first approach permits a fast and efficient detection of the glycosylated peptides as 48 different
glycopeptides, ranging from 950 to 3000 Da. For nanoLC-nESI-Orbitrap experiment, in addition
to the observation of neutral losses, oxonium ions, revealing the presence of glycans, were also
searched at m/z 204.09 (HexNAc)+, m/z 292.10 (NeuAc)+, or again at m/z 366.14 (Hex-HexNAc)+.
One-hundred eighty-one different glycopeptides were identified ranging from 897 to 6802 Da (Figure 1),
increasing the total of detected glycopeptides to 228. The retention times, charge states, and masses of
all these peptides are provided as supplementary material (Table S1).
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Figure 1. Venn diagram of compounds detected and the mass distribution of glycosylated peptides. 
Figure 1 also demonstrates that electrospray is more efficient than MALDI for the detection of 
glycosylated peptides (181 vs. 48), and especially for the mass range above 3.5 kDa. However, because 
only seven peptides are found using both ionization techniques, it is important to notice that the two 
analyses remain perfectly complementary. 
MALDI-PSD-TOF experiments allowed the full sequencing of 11 glycopeptides (Table 1). 
Annotated MS/MS spectra of each of these peptides are provided as supplementary material (Figure 
S1). All the sequences contain at least one threonine or one serine which, additionally to previous 
results obtained for this venom [10], supports the hypothesis of O-glycosylated peptides. 
Table 1. Glycosylated peptides discovered in D. angusticeps venom by the LC-MALDI-MS/MS approach. 
Name RT (min) Monoisotopic Mass (Da) 
Monoisotopic 
Mass w/o 
Glycan (Da) 
Sequence Glycan 
GlycoDa-01 7.75 1340.483 975.135 KNPTKPEY Hex-HexNAc 
GlycoDa-02 8.50 1411.567 1046.455 KNTPKPAEY Hex-HexNAc 
GlycoDa-03 9.00 1468.634 1103.491 KPPTELQYE Hex-HexNAc 
GlycoDa-04 9.25 1469.612 1104.447 KPPTELEYE Hex-HexNAc 
GlycoDa-05 9.50 1297.316 932.310 KPTNKSGSD Hex-HexNAc 
GlycoDa-06 9.50 1526.674 1161.340 KPEPTNGMAAF Hex-HexNAc 
GlycoDa-07 12.25 1073.53 708.196 PRSHAAA Hex-HexNAc 
GlycoDa-08 14.25 1144.554 779.316 PRSHAAAA Hex-HexNAc 
GlycoDa-09 17.50 1002.405 637.277 PRSHAA Hex-HexNAc 
GlycoDa-10 24.75 2164.089 1798.645 KSPPQALNKPLPAPSAPS Hex-HexNAc 
GlycoDa-11 26.50 2099.036 1733.885 KPPMVMSPKRPSPEPG Hex-HexNac 
Monosaccharide diversity. In addition to previously observed Hex and HexHexNAc O-
glycosylation, we detected two additional monosaccharide residues: sialic acid (Figure 2A) and 
fucose (Figure 3, glycoform B). In Figure 2A, the mass difference between the fragment m/z 1471.7079 
(z = 1) and the protonated parent m/z 1762.8083 (z = 1), corresponds to the exact mass of a  
SA (Mexp = 291.1004 Da, Mth = 291.0954 Da). The oxonium ions reported on the MS/MS spectra at m/z 
274.0920 and m/z 292.1025 are also characteristics of this atypical glycan. All this information clearly 
highlights the presence of SA in snake venoms, increasing the diversity of PTMs in peptide toxins. 
Based on the consecutive neutral loss pattern, a glycan structure is proposed in Figure 2A (insert). 
Harvey’s proposed O-linked carbohydrates nomenclature is used to illustrate all the glycan 
structures of this study [13]. Another glycopeptide carrying an unusual glycan has been characterized 
(Figure 2B). Neutral losses of 203.0809 Da, 162.0538 Da, and 146.0614 Da corresponding, respectively, 
to a loss of N-acetylhexosamine (HexNAc), hexose (Hex) and fucose (Fuc) were observed. 
Additionally, oxonium ions at m/z 204.0869 for HexNAc, m/z 274.0923 for SA, m/z 366.1398 for 
HexNAc-Hex, at m/z 512.2013 for HexNAc-Hex-Fuc, and at m/z 657.2364 for HexNAc-Hex-SA 
confirm the presence of these monosaccharides. Based on the molecular mass of the glycosylated 
peptide, neutral losses and molecular mass of the deglycosylated peptide (m/z 1078.5896, z = 1), two 
glycan structures are proposed for this toxin (Figure 2B). 
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Monosaccharide diversity. In addition to previously observed Hex and HexHexNAc O-glycosylation,
we detected two additional monosaccharide residues: sialic acid (Figure 2A) and fucose
(Figure 3, glycoform B). In Figure 2A, the mass difference between the fragment m/z 1471.7079
(z = 1) and the protonated parent m/z 1762.8083 (z = 1), corresponds to the exact mass of a SA
(Mexp = 291.1004 Da, Mth = 291.0954 Da). The oxonium ions reported on the MS/MS spectra at
m/z 274.0920 and m/z 292.1025 are also characteristics of this atypical glycan. All this information
clearly highlights the presence of SA in snake venoms, increasing the diversity of PTMs in peptide
toxins. Based on the consecutive neutral loss pattern, a glycan structure is proposed in Figure 2A
(insert). Harvey’s proposed O-linked carbohydrates nomenclature is used to illustrate all the glycan
structures of this study [13]. Another glycopeptide carrying an unusual glycan has been characterized
(Figure 2B). Neutral losses of 203.0809 Da, 162.0538 Da, and 146.0614 Da corresponding, respectively,
to a loss of N-acetylhexosamine (HexNAc), hexose (Hex) and fucose (Fuc) were observed. Additionally,
oxonium ions at m/z 204.0869 for HexNAc, m/z 274.0923 for SA, m/z 366.1398 for HexNAc-Hex,
at m/z 512.2013 for HexNAc-Hex-Fuc, and at m/z 657.2364 for HexNAc-Hex-SA confirm the presence
of these monosaccharides. Based on the molecular mass of the glycosylated peptide, neutral losses
and molecular mass of the deglycosylated peptide (m/z 1078.5896, z = 1), two glycan structures are
proposed for this toxin (Figure 2B).
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Figure 2. NUPLC-MS/MS spectra of peptide bearing O-glycans containing (A) sialic acid and  
(B) fucose. Carbohydrates are represented by the nomenclature proposed by Harvey et al. [13]. 
Oxonium ions are flagged by arrows. 
Figure 2. NUPLC-MS/MS spectra of peptide bearing O-glycans containing (A) sialic acid and (B) fucose.
Carbohydrates are represented by the nomenclature proposed by Harvey et al. [13]. Oxonium ions are
flagged by arrows.
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2. The determination of each glycosylation pattern was performed thanks to the presence of the 
signature oxonium ions corresponding of the glycan structure (for example m/z 366.1395 for Hex-
HexNAc structure, m/z 204.0867 for Hex-NAc, etc.). Six different glycan structures were determined 
in addition to non-glycosylated peptides already present in the venom. The glycosylation patterns of 
each peptide seems to occur randomly as no general behavior can be extracted from these data. 
A new family of highly modified peptides bearing atypical PTMs. Among the glycosylated 
peptides, one particular toxin detected in both MALDI and ESI experiments, retained our attention. 
Indeed, after a chemical reduction used to detect potential disulfide bridges, an unexpected loss of 
119 Da was observed for the peptide at m/z 2715.322 (RT = 17 min, supplementary material Table S2). 
The peptide was purified to consider a deeper investigation of this particular behavior. The new toxin 
was named GlycoDa-12. It was analyzed by Edman degradation to sequence the N-ter extremity and 
this revealed the presence of a hydroxylated proline at position 12 (data not shown). MALDI-TOF 
acquisition of the fraction containing GlycoDa-12 reveals the presence of four main peaks among 
which the toxin of interest at m/z 2715.322 (Figure 4A). After the reduction, the same unexpected loss 
of 119 Da was observed (Figure 4B). Interestingly, this loss is not only detectetabletabled for the most 
intense peak (P1), but also for the three others (P2, P3, and P4). Due to the selective reaction of the DTT 
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Glycoform diversity. Thanks to de novo sequencing and sequence homology with other sequences,
different glycoforms of the same peptide were identified, as demonstrated Figure 3 with the peptide
PRSHAAAA. Glycoform A (Figure 3, glycoform A) carries a HexNAc and a Hex, whereas Glycoform
B possesses an additional SA. This example highlights the complexity of this snake venom, which is
not only induced by the presence of analogous peptide sequences, discriminated by few mutations
(Table 1), but also based on a variable content of PTMs, such as glycosylation, which is expected,
following glycan synthesis pathway.
All the different glycosylation profiles that were observed in this work are summarized in Table 2.
The determination of each glycosylation pattern was performed thanks to the presence of the signature
oxonium ions corresponding of the glycan structure (for example m/z 366.1395 for Hex-HexNAc
structure, m/z 204.0867 for Hex-NAc, etc.). Six different glycan structures were determined in addition
to non-glycosylated peptides already present in the venom. The glycosylation patterns of each peptide
seems to occur randomly as no general behavior can be extracted from these data.
A new family of highly modified peptides bearing atypical PTMs. Among the glycosylated
peptides, one particular toxin detected in both MALDI and ESI experiments, retained our attention.
Indeed, after a chemical reduction used to detect potential disulfide bridges, an unexpected loss of
119 Da was observed for the peptide at m/z 2715.322 (RT = 17 min, supplementary material Table S2).
The peptide was purified to consider a deeper investigation of this particular behavior. The new toxin
was named GlycoDa-12. It was analyzed by Edman degradation to sequence the N-ter extremity and
this revealed the presence of a hydroxylated proline at position 12 (data not shown). MALDI-TOF
acquisition of the fraction containing GlycoDa-12 reveals the presence of four main peaks among
which the toxin of interest at m/z 2715.322 (Figure 4A). After the reduction, the same unexpected loss
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of 119 Da was observed (Figure 4B). Interestingly, this loss is not only detectetabletabled for the most
intense peak (P1), but also for the three others (P2, P3, and P4). Due to the selective reaction of the DTT
with disulfides, this result indicates that the same molecule was probably linked to the peptides by the
intermediary of a disulfide bridge. To validate this hypothesis, an alkylation (using iodoacetamide) was
performed to determine the number of cysteines in the sequence (+57 Da for each alkylated cysteine).
A single shift of 57 Da was measured indicating that only one cysteine is present. This behavior is also
observed for the three other peptides (Figure 4C).
Table 2. Glycoform diversity observed for different peptides.
Monoisotopic
Mass
w/o Glycan (Da)
Unmodified Hex-HexNAc
Hex2-
HexNAc2
NeuAc-
Hex-
HexNAc
NeuAc-
Hex2-
HexNAc
dHex-
Hex2-
HexNAc2
NeuAc-
dHex-
Hex2-
HexNAc2
637.36 X X X
779.43 X X X
1048.62 X X X
1077.58 X X X X X
1105.58 X X
1295.61 X X X
1311.68 X X X
1388.71 X X
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These overall results indicate that each of the four peptides possesses a single cysteine, linked to 
another molecule by a disulfide. This molecule displays a mass of 121.09 Da (loss of 119.07 Da + 2.02 
Da due to the addition of two hydrogens during the reduction). This mass corresponds to the mass 
of a free cysteine (Mexp = 121.09 Da, Mth = 121.02 Da). The nature of the modification is then definitely 
a S-cysteinylation, never described to date in snake venoms. MS/MS acquisition was performed from 
the reduced peptide (P1). Thanks to the b and y ions series present in the mass spectrum, as well as 
Edman sequencing data, the sequence DSIGSHSGLGCOGAGPRPKPTPGA* was unambiguously 
determined (Figure 5), where O designates a hydroxyproline residue and * corresponds to the 
amidation at the C-terminal extremity. 
Figure 4. Mass spectra of the S-Cys-GlycoDa-1 fraction in MALDI-MS acquisition. (A) crude fraction;
(B) reduced fraction; and (C) reduced and alkylated fraction.
These overall results indicate that each of the four peptides possesses a single cysteine, linked to
another molecule by a disulfide. This molecule displays a mass of 121.09 Da (loss of 119.07 Da + 2.02 Da
due to the addition of two hydrogens during the reduction). This mass corresponds to the mass of a
free cysteine (Mexp = 121.09 Da, Mth = 121.02 Da). The nature of the modification is then definitely a
S-cysteinylation, never described to date in snake venoms. MS/MS acquisition was performed from the
Int. J. Mol. Sci. 2017, 18, 2453 7 of 13
reduced peptide (P1). Thanks to the b and y ions series present in the mass spectrum, as well as Edman
sequencing data, the sequence DSIGSHSGLGCOGAGPRPKPTPGA* was unambiguously determined
(Figure 5), where O designates a hydroxyproline residue and * corresponds to the amidation at the
C-terminal extremity.
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hypothesis. The other peptides detected at m/z 2699, 2600, and 2513 (Figure 4A), display not only close 
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Table 3. Isoforms of GlycoDa-12—O: 4-trans-hydroxyproline; *: amidation at C-terminal extremity. 
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GlycoDa-12 2714.228 Da 2714.315 Da 
GlycoDa-13 2698.232 Da 2698.306 Da 
GlycoDa-14 2599.200 Da 2599.288 Da 
GlycoDa-15  
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Nuclear Magnetic Resonance. NMR investigations were achieved on the natural GlycoDa-12 isolated 
from the venom. The concentration of GlycoDa-12 for NMR analysis was estimated to 100 µM by 
measuring the signal intensity for the 4-methyl group (2 Leu and 2 Ile, at 0.8 ppm) relative to DSS as an 
internal standard. Since the amount of material was very limited, GlycoDa-12 was dissolved in D2O pH 
4.5 to limit the signal intensity loss due to imperfect water suppression and consequent baseline 
distortion. Unfortunately, the use of D2O prevented working with peptide NHs since they were quickly 
exchanged with deuterons and, therefore, the sequential assignment procedure as described by 
Wuthrich was not possible [14]. GlycoDa-12 seems to lack a stable structure. Indeed, neither NOESY 
nor ROESY signals were been observed down to 10°, which indicated a high flexibility for GlycoDa-12 
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As expected, a unique cysteine residue is present in sequence which validates the S-cysteinylation
hypothesis. The other peptides detected at m/z 2699, 2600, and 2513 (Figure 4A), display not only
close masses, identical isoelectric points (sa e SCX fraction), and hydrophobicities (same RP fraction),
but they also share the same chemical reactivity towards the reducing and alkylating reagents. All these
peptides constitute a new fa ily of isoforms, including a S-cysteinylation, MS/MS spectra of each
peptide confirm this hypothesis (Figures S2–S4); see Table 3.
Table 3. Isoforms of GlycoDa-12—O: 4-trans-hydroxyproline; *: amidation at C-terminal extremity.
Peptide Peptide Sequence Mth Mexp
GlycoDa-12
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distortion. Unfortunately, the use of D2O prevented working with peptide NHs since they were quickly 
exchanged with deuterons and, therefore, the sequential assignment procedure as described by 
Wuthrich was not possible [14]. GlycoDa-12 seems to lack a stable structure. Indeed, neither NOESY 
nor ROESY signals were been observed down to 10°, which indicated a high flexibility for GlycoDa-12 
DSIGSHSGLGCOGAGPRPKPTPGA* 
C 
DSIGSHSGLGCPGAGPRPKPTPGA* 
C 
SIGSHSGLGCOGAGPRPKPTPGA* 
C 
IGSHSGLGCOGAGPRPKPTPGA* 
C 
2714.228 Da 2714.315 Da
GlycoDa-13
Int. J. Mol. Sci. 2017, 18, 2453 7 of 13 
 
 
Figure 5. De novo sequencing of the m/z 2596 peptide in the S-Cys-GlycoDa-1 fraction; * internal 
fragments. Arrows indicate fragment ions identified in the mass spectra: a-type in green, y-type in 
blue and b-type in red. Carbohydrates are represented by the nomenclature proposed by Harvey et 
al. [13].  
As expected, a unique cystein  residue is present in sequence which validates the S-c steinylation 
hypothesis. The other peptides detected at m/z 2699, 2600, and 2513 (Figure 4A), display not only close 
masses, identical isoelectric points (same SCX fraction), and hydrophobicities (same RP fraction), but 
they also share the same chemical reactivity towards the reducing and alkylating reagents. All these 
peptides constitute a new family of isoforms, including a S-cysteinylation, MS/MS spectra of each 
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in D2O pH 4.5 o limit the s gnal nte sity loss due to imperfect water suppression and consequent
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were quickly exchanged with deuterons and, therefore, the sequential assignment procedure as
described by Wuthrich was not possible [14]. GlycoDa-12 seems to lack a stable structure. Indeed,
neither NOESY nor ROESY signals were been observed down to 10◦, which indicated a high flexibility
for GlycoDa-12 and an apparent absence of the stable secondary structure. Using 1H–13C [15] and
1H–13C HSQC-TOCSY [16], most of the amino acid side-chains were observed and identified (Figure 6).
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pH range. Surprisingly, His signals that are unambiguously identified by the correlation between the 
Hß and the imidazole CHs show significant chemical shift differences for natural GlycoDa-12 relative 
to synthesized peptide that cannot be explained with the pH difference. It seems that His chemical 
shift might be affected by the presence of the glycosylation on the threonine. The comparison with 
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oxidized Cys–SS–. Mass Spectrometry was used to follow the reaction and confirmed the addition of 
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oxidized Cys–SS– (Figure 7). This chemical shift difference corresponds to what is expected for Cys–
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at ral e tract f l co a-12 ith the synthesized peptide allowed a straightforward identification of
all the signals coming from the HexNAcHex. Eight CHO– and 2–O–CH were identified without
ambiguity. Unfortunately, because of severe overlap, the 2–CH2–O– could not be assigned with
confide ce. Since th synthesized pe tide was not glycosylated on the threonine, t iff r c
s r for the threonine Cβ chemical shift (Thr Cβ–OH: 4.2/70 ppm and Thr Cβ–O–Hex:
4.3/77.3 ppm) is a clear indication that the glycosylation in the natural GlycoDa-12 peptide took
place o the threo ine [17,18]. In order to identify the aspartate signals, the synthesized peptide
was analyzed at pH 4.5 and pH 1.2. The CH2β chemical shift modification due to pH difference
was then used to id ntify the aspartate that was the only amino acid that should show a different
chemical shift in that p ran e. Surprisingly, His signals that are unambigu usly identified by t
correlation between the Hß and the imidazole CHs show signifi ant chemic l shift differences for
natural GlycoDa-12 relative to synth sized peptide t at cannot be explained with t e p diff rence.
It see s t at His chemical s ift might be affected by the presence of the glycosylation n the threonine.
The comparison with the synthetized peptide l cking glycosylation and the Cys–SS–Cys disulfid
bridge allowed t identification of the cysteine in the main pepti chain. In order to i entify the
–SS–bridged cysteine, free cysteine was added to the synthetized peptide at pH 7.8 to convert the
reduc H into oxidized Cys–SS–. Mass Spectrometry was used to follow the reaction and
confirm d the addition of the cysteine. The comparison of both the synth tized peptide with re uc
t i or with oxidized cysteine indicated a Cβ that was shifted from 24.6 ppm for a reduced Cys–SH,
to 40.8 ppm for the oxidized Cys–SS– (Figure 7). This chemi al shift difference corresponds to what is
expected for Cys–SH and Cys–SS– [19,20].
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for threonine, NAcetyl hexose, leucine, and isoleucine are indicated in blue boxes. The 10 hexose CH 
are observed in pink boxes. CHα for the two cysteines, the histidine, the hydroxyl-proline, and the 
threonine are labeled. 
The subsequent comparison with the natural GlycoDa-12 peptide allowed to identify signals 
coming from the two oxidized Cys, confirming the existence of two Cys connected by a disulfide bridge. 
3. Discussion 
Among these 228 peptides, only seven (3%) are common to the two approaches. This low 
recovery can be explained by the fact that ionization mechanisms are not similar and may lead to 
preferential ionization of distinct families of peptides. Indeed, all of the 48 glycopeptides detected in 
MALDI carry the same glycan structure: an N-acetyl hexosamine (HexNAc) linked to a hexose (Hex), 
whereas the glycan diversity revealed by ESI is much more complex. Moreover, it has been shown 
that sialylated glycansn such as neuraminic acids, lose sialic acid groups during MALDI ionization 
[21], explaining why no glycopeptide bearing sialic acids have been detected by MALDI-MS. The 
high number of glycopeptides (221 unique in total) was not expected, and this is the first time that 
this diversity is observed from a snake venom. Even though there is no consensus sequence 
responsible of O-glycosylation identified yet, it has been notified that adjacent proline residues are 
often associated to O-glycosylation sites in humans [22]. This observation has already been discussed 
for glycosylated conotoxins [23]. All the discovered sequences also contain a large number of proline 
residues (from one to six), and, for half of them, additional alanines (one to four) (Table 1). This 
pattern of amino acids could constitute a partial explanation of the occurrence of these recurrent 
glycosylations. Even if it is not the first time that glycosylated peptides are identified in animal 
venoms, it is interesting to remark that this study highlights, for the first time, not only a large group 
of glycopeptides sharing the same glycosylation structure and sequence similarities, but also the 
presence of sialic acid and fucose in the O-glycan structures. Based on these results and despite the 
advanced technology available, it is obvious that unsuspected compounds’ families remain to be 
discovered in animal venoms. 
GlycoDa-12 to -15 constitute a new family of peptides displaying very unusual PTMs. This family 
displays five prolines and two alanines, partially explaining their O-glycosylation [22]. Hydroxylation 
of proline(s) was determined by Edman degradation and by comparison with the P2 isoform which 
displays a classical proline instead of the hydroxyproline. This PTM, usually encountered in cone snail 
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si lylated glycansn such as neuraminic acids, lo e sialic c d groups during MALDI ionization [21],
explaining why no glycopeptide bearing sialic ac ds have been d tect d by MALDI-MS. The high
number of glycopeptides (221 uniq e in total) was not expected, and this is the first time that this
diversity i observed f om a snake venom. Even though there is no cons n us sequence re ponsible of
O-glycosylation identified yet, it has be n notified that adjacent proline residu s are ften as ociated to
O-glycosyl tion sites in hum ns [22]. This observation has already bee di cusse for glycosylat
conotoxins [23]. All the discovered sequences also contain a large number of proline residues ( rom o e
to six), and, for half f them, a dition alanin s (one to four) (Table 1). This patte n of amino acids
could constitute a partial explanation of the occurr nce of these recurrent glycosylations. Ev n if it is
not the first time that glyco ylated peptides ar identified in animal venom , it is interesting to remark
that this study highl ghts, for the first time, not only a large group o glycop ptides sharing the same
glycosylation structure and sequence similarities, but also the pr sence of sialic acid and fuc se in
th O-glycan structures. Based on these results and despite the adva ced t chno ogy available, it is
ob ious that u suspected compounds’ families remain to be discovered i animal venoms.
GlycoDa-12 to -15 constitute a new family of peptides displaying very unusual PTMs. This family
displays five prolines and two alanines, ar ally expla ing their O-glycosylat on [22].
Hydroxylation of proline(s) w s determined by Edman degradation and by comparison with
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the P2 isoform which displays a classical proline instead of the hydroxyproline. This PTM,
usually encountered in cone snail toxin, has not yet been reported in the literature for snake
venoms. A basic local alignment sequence result shows high level sequence homology with the
C-ter snake natriuretic peptides found in the Elapidae Pseudechis, Cryptophis, Suta, and Hoplocephalus
snake genders ([24], Figure 8). Based on the sequence alignment, it is remarkable that polyproline
chain, as well as the cysteine residues, are conserved among all the sequences. The main difference
between GlycoDa-12 and the natriuretic peptides is the absence of a conserved disulfide bond between
Cys12 and Cys28. Indeed, GlycoDa-12 to 15 are smaller than the other peptides, which may indicate
that GlycoDa12 to 15 are only degraded peptides, in which the disulfide has been reduced and the
peptide chain cleaved probably through an enzymatic pathway. The S-cysteinylation was probably
added to the peptide a second time. However, it is also interesting to observe the large diversity in
terms of amino acids provided by GlycoDa-12. Indeed, the well-conserved residues in positions 19, 23,
29 (31), and 41 are different in GlycoDa-12. Concerning the glycosylation, bored by the final threonine,
could not be observed by St. Pierre et al. [24] because the sequences were obtained thanks to a
transcriptomics approach which is not capable of detecting post-translational modifications. However,
based on the amino acid sequence, and on previous work on O-glycosylation, it was shown that the
frequency of occurrence of proline residues increases around the O-glycosylation sites, especially when
Pro is localized at the position n − 1 [22]. This information, added to the fact that the position +37 and
+38 are highly conserved, strongly suggest the glycosylation of all the natriuretic peptides discovered
from snake venoms.
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Two natriuretic peptides have already been found in Dendroaspis venom and were named DNP 
and DNP-2 for Dendroaspis natriuretic peptide [25,26]. They target atrial natriuretic peptide-A 
receptors and induce vascular relaxation and natriuresis. Such natriuretic peptides could be involved 
in the treatment of congestive heart failure and hypertension [27–28]. 
4. Material and Methods 
Venom: Crude venom of Dendroaspis angusticeps was purchase from Latoxan (France). 
UPLC-MALDI-MS: Venom analysis was performed on an Acquity I-Class UPLC from Waters 
(Manchester, UK). Five micrograms of crude venom were loaded on an Acquity peptide BEH300 C18 
column (1 mm × 15 cm 300 Ȧ, Waters, Manchester, UK) and eluted with a gradient of 0–40% of 
solution B in 50 min (A: H2O/FA 0.1%; B: 98% ACN/1.9% H2O/FA 0.1%) at a flow rate of 70 µL/min. 
The eluate was dropped on-line onto a MALDI plate thanks to the Probot MALDI spotter (Thermo 
Scientific, Waltham, MA, USA), for 15 seconds/position. MALDI mass spectrometer acquisitions were 
performed with an Ultraflex II from Bruker Daltonics (Bruker Daltonics, Bremen, Germany). An 
anchorchip MALDI plate was used with α-cyano-4-hydroxycinnamic acid from Sigma Aldrich  
(St. Louis, MO, USA) as the MALDI matrix. Data analysis was performed with flexAnalysis software 
(Bruker Daltonics). 
nanoUPLC-ESI-MS: Following UPLC-MALDI-MS results, the first minute LC fraction 
containing glycosylated peptides revealed by MALDI-MS were collected and analyzed by 
nanoUPLC-ESI-MS. In order to prevent glycopeptides loss during the loading on the nanocolumn, 
an HSS T3 reverse phase column (75 µm × 25 cm 100 , Waters) which shows more retentivity 
(advised by the manufacturer), was used. Venom fraction analysis was performed thanks to an 
Acquity M-Class UPLC from Waters using an Acquity peptide HSST3 C18 column and eluted with a 
Identification Species 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42
GlycoDa-12 D. angusticeps - - - - - - - - - - - - - - - - - D S I G S H S G L G C P G A G P R P K P T P G A -
Q3SAF1 P.porphyriacus S G S K T A N I G D G C F G V P I D H I G S T S G M G C G S - - P R P K P T P G G S
Q3SAF3 P.australis S G S K T A E I G D G C F G V P I D H I G S T S G M G C G R - - P R P K P T P G G S
Q3SAF0 P.porphyriacus S G S K T A N I G D G C F G V R L D H I G T T S G M G C G R - - P R P K P T P G G S
R4G340 S. fasciata S D S K T A T K G N G C F G V R I D R I G S V S G M G C G G - - - K P K P T P G G S
Q1ZYW0 C. nigrescens S G S K T A T K G D G C F G V R I D R I G S T S G M G C G G - - - V P K P T P G G S
Q1ZYW1 C. nigrescens S G S K T A K I G D G C F G V R I D R I G S T S G M G C G G - - - V P K P T P G G S
Q3SAE6 H. stephensii S G S K T A K I G D G C F G V R L D R I G S T S G M G C G G - - - V P K P T P G G S
i . lt f l - t i . , i , i l i i i
iffere t than database sequences.
Two natriuretic peptides have already been found in Dendroaspis venom and were named DNP
and DNP-2 for Dendroaspis natriuretic peptide [25,26]. They target atrial natriuretic peptide-A receptors
and induce vascular relaxation and natriuresis. Such natriuretic peptides could be involved in the
treatment of congestive heart failure and hypertension [27,28].
4. aterial and ethods
Veno : Crude veno of Dendroaspis angusticeps as purchase from Latoxan (France).
PLC- L I- S: Veno analysis as perfor ed on an cquity I-Class PLC fro aters
( anchester, K). Five icrograms of crude venom were loaded on an Acquity peptide BEH300
C18 column (1 mm × 15 cm 300 A˙, Waters, Manchester, UK) and eluted with a gradient of 0–40%
of solution B in 50 min (A: H2O/FA 0.1%; B: 98% ACN/1.9% H2O/FA 0.1%) at a flow rate of
70 µL/min. The eluate was dropped on-line onto a MALDI plate thanks to the Probot MALDI
spotter (Thermo Scientific, Waltham, MA, USA), for 15 seconds/position. MALDI mass spectrometer
acquisitions were performed with an Ultraflex II from Bruker Daltonics (Bruker Daltonics, Bremen,
Germany). An anchorchip MALDI plate was used with α-cyano-4-hydroxycinnamic acid from Sigma
Aldrich (St. Louis, MO, USA) as the MALDI matrix. Data analysis was performed with flexAnalysis
software (Bruker Daltonics).
nanoUPLC-ESI- S: Following UPLC-MALDI-MS results, the first minute LC fraction containing
glycosylated peptides revealed by MALDI-MS were collected and analyzed by nanoUPLC-ESI-MS.
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In order to prevent glycopeptides loss during the loading on the nanocolumn, an HSS T3 reverse phase
column (75 µm × 25 cm 100 A˙, Waters) which shows more retentivity (advised by the manufacturer),
was used. Venom fraction analysis was performed thanks to an Acquity M-Class UPLC from Waters
using an Acquity peptide HSST3 C18 column and eluted with a gradient of 2 to 7% of solution B in
10 min, 7 to 30% of solution B in 62 min and 30 to 40% in 25 min (A: H2O/FA 0.1%; B: 99.9% ACN/FA
0.1%) at a flow rate of 0.6 µL/min. The UPLC system is hyphenated with an Orbitrap mass spectrometer
with a nanoESI source from Thermo (Thermo Scientific, Waltham, MA, USA) (Q-Exactive). The analysis
was performed in “DDA mode” (data dependent analysis) that automatically triggers the MS/MS
experiments. Automatic gain control (AGC) target values were 106 for MS spectra and 105 for
MS/MS spectra. The maximum injection times were set at 200 ms for MS and MS/MS events.
The 10 top-most intense peaks of each MS scan were fragmented by high-energy dissociation (HCD)
and their corresponding MS/MS spectra were acquired in the Orbitrap analyzer to take benefit of the
high accuracy and resolution of this analyzer. Data analysis was performed with Xcalibur Qualbrowser
(Thermo Scientific).
NMR spectroscopy: NMR spectra were recorded on a Bruker 500 MHz Avance I spectrometer
equipped with a 5 mm TCI cryogenic-probe. Samples were in D2O without buffer and the pH was
set to 1.2 or 4.5 with DCl or NaOD solution. Edited 13C-1H HSQC, were recorded using a standard
Bruker pulse sequence (hsqcedetgpsisp2.4). For Da2DH natural extract at a concentration of 100 µM,
160 scans per increment were recorded using 2048 points in the proton dimension, and 256 increments
in the 13C dimension. 13C-1H HSQC-TOCSY were recorded using standard Bruker pulse sequence
(hsqcdietgpsisp.2). For Da2DH natural extract at a concentration of 100 µM, 256 scans per increment
were recorded using 1024 points in the proton dimension and 512 increments in the 13C dimension.
The TOCSY spinlock time was 120 ms. All data were processed using TOPSPIN 3.5.
Detection of the glycopeptides: Each MS/MS spectrum was manually interpreted by the authors
in order to prevent the identification of false positives. Glycopeptide detection was determined
thanks to the observation of neutral losses corresponding to specific glycan structures (see the Results
section). Furthermore, the presence of oxonium ions in the low mass range of MS/MS spectra was also
screened to confirm the presence of glycans. MS/MS tolerance was set to 0.5 Da for MALDI-PSD-TOF
experiments and to 5 ppm when using an Orbitrap analyser. In addition, several peptide sequences
were determined when sufficient informative fragments (a-, b-, and/or y-) were detected.
5. Conclusions
This structural work reports the unusual presence of PTMs in snake venom peptidomes, such as
hydroxyproline, O-glycosylation, and S-cysteinylation. However, all these PTMs have already been
described in cone snail venom, this is the first time that a study highlights such modifications in snake
venom. Fifteen new fully-characterized toxins were reported in this work and glycosylation sites were
confirmed thanks to orthogonal analytical techniques, such as nuclear magnetic resonance.
More generally, it is appearing that the study of a venom peptidome cannot be reduced to the
characterization of simple classical peptides/toxins, but must also include not only the glycopeptidome,
but quite probably the phospho-, the sulfo- or, again, the lipido-peptidome. As a single transcriptomic
study is not capable to identify PTMs, proteomics approaches are unavoidable when the description
of a venom composition is considered. In the meantime, the same cautiousness must be taken into
account for sequence alignment with already-known database toxin sequences. For future sequencing
investigations, a major analytical challenge has to also be considered due to the S-cysteinylation,
which becomes unidentifiable after the reduction disulfides step. Although it has been reported
that S-cysteinylation has a role during the interaction of a conotoxin and the Nav1.2 ion channel,
biological significance of all these PTMs will have to be investigating in order to understand the role of
these toxins in snake venom.
In any case, animal venoms are still far from having delivered all their secrets and technological
progress will help, day after day, to pierce their mysteries.
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